<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for shSCR 1549053414829 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN'>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN</a></td><td><a href='KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN.html'>Details ...</a></td><td>54</td><td>-0.40</td><td>-2.55</td><td>0.000</td><td>0.003</td><td>0.005</td><td>175</td><td>tags=80%, list=43%, signal=122%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_CLASSES_UP'>CAIRO_HEPATOBLASTOMA_CLASSES_UP</a></td><td><a href='CAIRO_HEPATOBLASTOMA_CLASSES_UP.html'>Details ...</a></td><td>24</td><td>-0.43</td><td>-2.08</td><td>0.000</td><td>0.048</td><td>0.131</td><td>188</td><td>tags=88%, list=46%, signal=154%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN'>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN</a></td><td><a href='KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN.html'>Details ...</a></td><td>44</td><td>-0.34</td><td>-1.99</td><td>0.000</td><td>0.061</td><td>0.238</td><td>175</td><td>tags=77%, list=43%, signal=121%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WONG_EMBRYONIC_STEM_CELL_CORE'>WONG_EMBRYONIC_STEM_CELL_CORE</a></td><td><a href='WONG_EMBRYONIC_STEM_CELL_CORE.html'>Details ...</a></td><td>15</td><td>-0.48</td><td>-1.94</td><td>0.007</td><td>0.066</td><td>0.331</td><td>174</td><td>tags=87%, list=43%, signal=146%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DOUGLAS_BMI1_TARGETS_UP'>DOUGLAS_BMI1_TARGETS_UP</a></td><td><a href='DOUGLAS_BMI1_TARGETS_UP.html'>Details ...</a></td><td>24</td><td>-0.38</td><td>-1.84</td><td>0.017</td><td>0.101</td><td>0.553</td><td>69</td><td>tags=42%, list=17%, signal=47%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3'>MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3</a></td><td><a href='MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3.html'>Details ...</a></td><td>24</td><td>-0.36</td><td>-1.74</td><td>0.021</td><td>0.153</td><td>0.759</td><td>39</td><td>tags=33%, list=10%, signal=35%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_CANCER_UP'>GRADE_COLON_CANCER_UP</a></td><td><a href='GRADE_COLON_CANCER_UP.html'>Details ...</a></td><td>28</td><td>-0.34</td><td>-1.72</td><td>0.017</td><td>0.146</td><td>0.782</td><td>109</td><td>tags=50%, list=27%, signal=64%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1'>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</a></td><td><a href='CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1.html'>Details ...</a></td><td>18</td><td>-0.37</td><td>-1.58</td><td>0.043</td><td>0.287</td><td>0.970</td><td>173</td><td>tags=83%, list=43%, signal=139%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_BASAL_UP'>SMID_BREAST_CANCER_BASAL_UP</a></td><td><a href='SMID_BREAST_CANCER_BASAL_UP.html'>Details ...</a></td><td>15</td><td>-0.39</td><td>-1.57</td><td>0.039</td><td>0.261</td><td>0.971</td><td>18</td><td>tags=27%, list=4%, signal=27%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN'>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</a></td><td><a href='CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN.html'>Details ...</a></td><td>31</td><td>-0.29</td><td>-1.51</td><td>0.048</td><td>0.323</td><td>0.990</td><td>82</td><td>tags=39%, list=20%, signal=45%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DANG_BOUND_BY_MYC'>DANG_BOUND_BY_MYC</a></td><td><a href='DANG_BOUND_BY_MYC.html'>Details ...</a></td><td>37</td><td>-0.27</td><td>-1.50</td><td>0.047</td><td>0.311</td><td>0.991</td><td>164</td><td>tags=62%, list=40%, signal=95%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MARTENS_TRETINOIN_RESPONSE_DN'>MARTENS_TRETINOIN_RESPONSE_DN</a></td><td><a href='MARTENS_TRETINOIN_RESPONSE_DN.html'>Details ...</a></td><td>30</td><td>-0.29</td><td>-1.44</td><td>0.079</td><td>0.366</td><td>0.997</td><td>143</td><td>tags=63%, list=35%, signal=91%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DODD_NASOPHARYNGEAL_CARCINOMA_DN'>DODD_NASOPHARYNGEAL_CARCINOMA_DN</a></td><td><a href='DODD_NASOPHARYNGEAL_CARCINOMA_DN.html'>Details ...</a></td><td>36</td><td>-0.26</td><td>-1.41</td><td>0.084</td><td>0.393</td><td>0.999</td><td>148</td><td>tags=61%, list=37%, signal=88%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_WITH_H3K27ME3'>BENPORATH_ES_WITH_H3K27ME3</a></td><td><a href='BENPORATH_ES_WITH_H3K27ME3.html'>Details ...</a></td><td>16</td><td>-0.31</td><td>-1.31</td><td>0.142</td><td>0.554</td><td>1.000</td><td>87</td><td>tags=50%, list=21%, signal=61%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN'>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN</a></td><td><a href='GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN.html'>Details ...</a></td><td>25</td><td>-0.26</td><td>-1.24</td><td>0.215</td><td>0.690</td><td>1.000</td><td>167</td><td>tags=68%, list=41%, signal=109%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP'>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</a></td><td><a href='MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP.html'>Details ...</a></td><td>18</td><td>-0.29</td><td>-1.22</td><td>0.218</td><td>0.688</td><td>1.000</td><td>293</td><td>tags=100%, list=72%, signal=346%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP'>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP</a></td><td><a href='KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP.html'>Details ...</a></td><td>24</td><td>-0.25</td><td>-1.22</td><td>0.204</td><td>0.660</td><td>1.000</td><td>135</td><td>tags=54%, list=33%, signal=76%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/NUYTTEN_EZH2_TARGETS_DN'>NUYTTEN_EZH2_TARGETS_DN</a></td><td><a href='NUYTTEN_EZH2_TARGETS_DN.html'>Details ...</a></td><td>29</td><td>-0.24</td><td>-1.22</td><td>0.207</td><td>0.633</td><td>1.000</td><td>147</td><td>tags=59%, list=36%, signal=85%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN'>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</a></td><td><a href='GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN.html'>Details ...</a></td><td>15</td><td>-0.29</td><td>-1.18</td><td>0.252</td><td>0.694</td><td>1.000</td><td>116</td><td>tags=53%, list=29%, signal=72%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP'>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP</a></td><td><a href='KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP.html'>Details ...</a></td><td>31</td><td>-0.22</td><td>-1.17</td><td>0.273</td><td>0.680</td><td>1.000</td><td>107</td><td>tags=39%, list=26%, signal=49%</td></tr><tr><td class='lessen'>21</td><td>CHICAS_RB1_TARGETS_SENESCENT</td><td></td><td>26</td><td>-0.22</td><td>-1.12</td><td>0.342</td><td>0.770</td><td>1.000</td><td>44</td><td>tags=23%, list=11%, signal=24%</td></tr><tr><td class='lessen'>22</td><td>BENPORATH_MYC_MAX_TARGETS</td><td></td><td>25</td><td>-0.23</td><td>-1.10</td><td>0.347</td><td>0.791</td><td>1.000</td><td>134</td><td>tags=52%, list=33%, signal=73%</td></tr><tr><td class='lessen'>23</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>16</td><td>-0.27</td><td>-1.09</td><td>0.344</td><td>0.764</td><td>1.000</td><td>125</td><td>tags=56%, list=31%, signal=78%</td></tr><tr><td class='lessen'>24</td><td>ONKEN_UVEAL_MELANOMA_UP</td><td></td><td>25</td><td>-0.23</td><td>-1.08</td><td>0.355</td><td>0.770</td><td>1.000</td><td>77</td><td>tags=32%, list=19%, signal=37%</td></tr><tr><td class='lessen'>25</td><td>BENPORATH_ES_1</td><td></td><td>15</td><td>-0.27</td><td>-1.07</td><td>0.364</td><td>0.758</td><td>1.000</td><td>147</td><td>tags=60%, list=36%, signal=91%</td></tr><tr><td class='lessen'>26</td><td>PHONG_TNF_RESPONSE_NOT_VIA_P38</td><td></td><td>19</td><td>-0.25</td><td>-1.06</td><td>0.377</td><td>0.740</td><td>1.000</td><td>83</td><td>tags=42%, list=20%, signal=50%</td></tr><tr><td class='lessen'>27</td><td>LEE_BMP2_TARGETS_DN</td><td></td><td>20</td><td>-0.24</td><td>-1.06</td><td>0.388</td><td>0.730</td><td>1.000</td><td>149</td><td>tags=60%, list=37%, signal=90%</td></tr><tr><td class='lessen'>28</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN</td><td></td><td>22</td><td>-0.22</td><td>-1.04</td><td>0.382</td><td>0.732</td><td>1.000</td><td>74</td><td>tags=32%, list=18%, signal=37%</td></tr><tr><td class='lessen'>29</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN</td><td></td><td>15</td><td>-0.26</td><td>-1.03</td><td>0.409</td><td>0.739</td><td>1.000</td><td>89</td><td>tags=40%, list=22%, signal=49%</td></tr><tr><td class='lessen'>30</td><td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td><td></td><td>15</td><td>-0.25</td><td>-1.02</td><td>0.417</td><td>0.725</td><td>1.000</td><td>67</td><td>tags=33%, list=17%, signal=38%</td></tr><tr><td class='lessen'>31</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>25</td><td>-0.20</td><td>-0.95</td><td>0.523</td><td>0.860</td><td>1.000</td><td>35</td><td>tags=20%, list=9%, signal=21%</td></tr><tr><td class='lessen'>32</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN</td><td></td><td>52</td><td>-0.15</td><td>-0.94</td><td>0.546</td><td>0.854</td><td>1.000</td><td>123</td><td>tags=40%, list=30%, signal=51%</td></tr><tr><td class='lessen'>33</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP</td><td></td><td>57</td><td>-0.15</td><td>-0.92</td><td>0.591</td><td>0.884</td><td>1.000</td><td>269</td><td>tags=86%, list=66%, signal=220%</td></tr><tr><td class='lessen'>34</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING</td><td></td><td>17</td><td>-0.22</td><td>-0.91</td><td>0.578</td><td>0.876</td><td>1.000</td><td>148</td><td>tags=59%, list=37%, signal=89%</td></tr><tr><td class='lessen'>35</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>17</td><td>-0.21</td><td>-0.91</td><td>0.572</td><td>0.854</td><td>1.000</td><td>251</td><td>tags=88%, list=62%, signal=222%</td></tr><tr><td class='lessen'>36</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td><td></td><td>16</td><td>-0.22</td><td>-0.90</td><td>0.599</td><td>0.836</td><td>1.000</td><td>127</td><td>tags=56%, list=31%, signal=79%</td></tr><tr><td class='lessen'>37</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN</td><td></td><td>19</td><td>-0.20</td><td>-0.89</td><td>0.595</td><td>0.832</td><td>1.000</td><td>327</td><td>tags=100%, list=81%, signal=495%</td></tr><tr><td class='lessen'>38</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A</td><td></td><td>23</td><td>-0.19</td><td>-0.88</td><td>0.621</td><td>0.829</td><td>1.000</td><td>66</td><td>tags=26%, list=16%, signal=29%</td></tr><tr><td class='lessen'>39</td><td>SENESE_HDAC3_TARGETS_DN</td><td></td><td>21</td><td>-0.20</td><td>-0.88</td><td>0.600</td><td>0.819</td><td>1.000</td><td>20</td><td>tags=14%, list=5%, signal=14%</td></tr><tr><td class='lessen'>40</td><td>BENPORATH_CYCLING_GENES</td><td></td><td>17</td><td>-0.20</td><td>-0.84</td><td>0.665</td><td>0.873</td><td>1.000</td><td>85</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>41</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</td><td></td><td>15</td><td>-0.21</td><td>-0.84</td><td>0.644</td><td>0.858</td><td>1.000</td><td>67</td><td>tags=27%, list=17%, signal=31%</td></tr><tr><td class='lessen'>42</td><td>FEVR_CTNNB1_TARGETS_UP</td><td></td><td>23</td><td>-0.18</td><td>-0.83</td><td>0.700</td><td>0.845</td><td>1.000</td><td>49</td><td>tags=22%, list=12%, signal=23%</td></tr><tr><td class='lessen'>43</td><td>PENG_GLUTAMINE_DEPRIVATION_DN</td><td></td><td>15</td><td>-0.21</td><td>-0.81</td><td>0.663</td><td>0.855</td><td>1.000</td><td>326</td><td>tags=100%, list=80%, signal=494%</td></tr><tr><td class='lessen'>44</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>18</td><td>-0.19</td><td>-0.81</td><td>0.709</td><td>0.840</td><td>1.000</td><td>125</td><td>tags=50%, list=31%, signal=69%</td></tr><tr><td class='lessen'>45</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP</td><td></td><td>30</td><td>-0.15</td><td>-0.81</td><td>0.727</td><td>0.827</td><td>1.000</td><td>252</td><td>tags=83%, list=62%, signal=204%</td></tr><tr><td class='lessen'>46</td><td>NUYTTEN_NIPP1_TARGETS_DN</td><td></td><td>33</td><td>-0.15</td><td>-0.79</td><td>0.743</td><td>0.829</td><td>1.000</td><td>95</td><td>tags=33%, list=23%, signal=40%</td></tr><tr><td class='lessen'>47</td><td>LIAO_METASTASIS</td><td></td><td>21</td><td>-0.17</td><td>-0.77</td><td>0.767</td><td>0.839</td><td>1.000</td><td>191</td><td>tags=71%, list=47%, signal=128%</td></tr><tr><td class='lessen'>48</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>16</td><td>-0.18</td><td>-0.75</td><td>0.796</td><td>0.852</td><td>1.000</td><td>336</td><td>tags=100%, list=83%, signal=564%</td></tr><tr><td class='lessen'>49</td><td>BOCHKIS_FOXA2_TARGETS</td><td></td><td>16</td><td>-0.18</td><td>-0.70</td><td>0.838</td><td>0.899</td><td>1.000</td><td>151</td><td>tags=56%, list=37%, signal=86%</td></tr><tr><td class='lessen'>50</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td><td></td><td>18</td><td>-0.15</td><td>-0.65</td><td>0.857</td><td>0.936</td><td>1.000</td><td>348</td><td>tags=100%, list=86%, signal=679%</td></tr><tr><td class='lessen'>51</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td><td></td><td>16</td><td>-0.14</td><td>-0.58</td><td>0.960</td><td>0.969</td><td>1.000</td><td>172</td><td>tags=63%, list=42%, signal=104%</td></tr><tr><td class='lessen'>52</td><td>PUJANA_CHEK2_PCC_NETWORK</td><td></td><td>19</td><td>-0.10</td><td>-0.42</td><td>0.995</td><td>0.998</td><td>1.000</td><td>6</td><td>tags=5%, list=1%, signal=5%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>shSCR (3 samples)<b>&nbsp<a href='gsea_report_for_shSCR_1549053414829.xls'>[plain text format]</a></caption></table></div><br></body></html>